Background: Somatostatin receptor 2, 5 (SSTR2, SSTR5) were seldom investigated in gastric neuroendocrine neoplasms (G-NENs). The purpose of the study was to elucidate the expression of SSTR2, SSTR5 in G-NENs and related clinical significance.Methods: 66 paraffin-embedded specimens were obtained from The first affiliated hospital of Zhengzhou university. The expression of SSTR2 and SSTR5 was detected by immunohistochemistry. The expression of SSTR2, SSTR5 and the clinicopathological characteristics, related immunohistochemical molecules and prognosis of gastric neuroendocrine neoplasm were analyzed statistically.Results: The expression rate of SSTR2 protein in G-NENs tissues and normal stomach tissues was 48.5% and 25.0%, respectively (P=0.046); the expression rate of SSTR5 protein in G-NENs tissues and normal stomach tissues was 65.2% and 25.0% , respectively (P=0.018). The expression of SSTR2 was positively correlated with the expression of Ki-67, SSTR5 and tumor grade (P-value was 0.032, 0.002, and 0.005, respectively); the expression of SSTR5 was positively correlated with the expression of SSTR2, Ki-67, CD-56 and tumor grade (P-value was 0.032, 0.011, 0.008, 0.028, respectively). In the SSTR2-positive group, SSTR5, CD-56, Ki-67 were closely related to the prognosis of patients with G-NENs. In the SSTR5-positive group, tumor grade, SSTR2, CD-56, Ki-67 were closely related to the prognosis of patients with G-NENs. Multi-factor analysis showed that SSTR2 and SSTR5 were independent prognostic factors for patients with G-NENs. Conclusion. High expression of SSTR2 and SSTR5 protein was related to the tumorigenesis of G-NENs. SSTR2 and SSTR5 were associated with the prognosis and might improve the prognosis of G-NENs.